- Astra Zeneca vaccine does not protect against mild-to-moderate Covid-19 due to the South African variant. https://www.nejm.org/doi/full/10.1056/nejmoa2102214?query=featured_coronavirus 174 comments science
Linking pages
- https://sigallab.net/ 16 comments
- COVID is surging in the world's most vaccinated country. Why? https://theconversation.com/covid-is-surging-in-the-worlds-most-vaccinated-country-why-160869 10 comments
- AstraZeneca Vaccine Fails To Protect Against The South African Variant, Says Study https://www.forbes.com/sites/williamhaseltine/2021/03/17/astrazeneca-vaccine-fails-to-protect-against-the-south-african-variant/ 4 comments
- Novelty Means Severity: The Key To the Pandemic - by zeynep https://www.theinsight.org/p/novelty-means-severity-the-key-to 1 comment
- How worried should you be about coronavirus variants? A virologist explains his concerns https://theconversation.com/how-worried-should-you-be-about-coronavirus-variants-a-virologist-explains-his-concerns-158360 0 comments
- Why England is dangerously exposed to new Covid-19 variants https://www.newstatesman.com/science-tech/coronavirus/2021/03/why-england-dangerously-exposed-new-covid-19-variants 0 comments
- Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination | NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2110716 0 comments
- Authorities raise red flags about AstraZeneca’s vaccine press release [Updated] | Ars Technica https://arstechnica.com/science/2021/03/authorities-raise-red-flags-about-astrazenecas-vaccine-press-release/ 0 comments
Linked pages
- https://ir.novavax.com/news-releases/news-release-details/novavax-covid-19-vaccine-demonstrates-893-efficacy-uk-phase-3 290 comments
- Johnson & Johnson COVID-19 Vaccine Authorized by U.S. FDA For Emergency Use | Johnson & Johnson https://www.jnj.com/johnson-johnson-announces-single-shot-janssen-covid-19-vaccine-candidate-met-primary-endpoints-in-interim-analysis-of-its-phase-3-ensemble-trial 23 comments
- https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-announce-vaccine-candidate-against 4 comments
- https://investors.modernatx.com/news-releases/news-release-details/modernas-covid-19-vaccine-candidate-meets-its-primary-efficacy 2 comments
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2034577 1 comment
- Neutralizing Activity of BNT162b2-Elicited Serum | NEJM https://www.nejm.org/doi/full/10.1056/NEJMc2102017 0 comments
- COVID-19 vaccine tracker and landscape https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines 0 comments
- https://www.jnj.com/coronavirus/covid-19-phase-3-study-clinical-protocol 0 comments
- VV116 versus Nirmatrelvir–Ritonavir for Oral Treatment of Covid-19 | NEJM https://www.nejm.org/doi/full/10.1056/NEJMoa2208822 0 comments
Related searches:
Search whole site: site:doi.org
Search title: Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 Variant | NEJM
See how to search.